5098-11-3Relevant articles and documents
SYNTHESIS AND PROPERTIES OF ANALOGS OF 5(OR 4)-AMINOIMIDAZOLE-4(OR 5)-CARBOXAMIDE (AICA) AND PURINES. 12. INVESTIGATION OF THE INTERACTION OF 4-CHLOROIMIDAZO-1,2,3-TRIAZINE WITH NUCLEOPHILES
Mokrushin, V. S.,Pospelova, T. A.,Shafran, Yu. M.
, p. 1231 - 1234 (1983)
The reactions of 4-chloroimidazo-1,2,3-triazine with a number of nucleophilic reagents have been studied.Either replacement of the chlorine atom in position 4 of the 1,2,3-triazine ring or opening of the triazine ring with the formation of products of the interaction of the intermediate 5-diazoimidazole-4-carbonitrile with these nucleophiles occurs, depending on the nucleophilicity of the reagent.
Ferris,Orgel
, p. 1074 (1966)
METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)IMIDATE, METHOD FOR PRODUCTION OF N-(2-AMINO-1,2-DICYANOVINYL)FORMAMIDINE, AND METHOD FOR PRODUCTION OF AMINOIMIDAZOLE DERIVATIVE
-
Page/Page column 15, (2010/01/07)
A method for producing N-(2-amino-1,2-dicyanovinyl)imidates represented by the following formula (1-III) under low temperature conditions within a short period of time in high yield is provided. In addition, a method for producing N-(2-amino-1,2-dicyanovinyl)formamidine represented by the following formula (2-II) which is suitably applicable to a cyclization reaction for producing AICN, AICA or the like and which enhances yield of the cyclization reaction is provided. In addition, a method for producing aminoimidazole derivatives represented by the following formula (3-V) in high yield by using diaminomaleonitrile as a starting material is provided.
DNA Methyltransferase inhibitors
-
Page 24, (2008/06/13)
A compound of the formula or a pharmaceutically acceptable salt thereof,whereinR1, R2, and R3 are the same or different and are independently hydrogen, lower alkyl, aryl or substituted aryl, lower alkoxy, lower alkoxyalkyl, or cycloalkyl or cycloalkyl alkoxy, where each cycloalkyl group has from 3-7 members, where up to two of the cycloalkyl members are optionally hetero atoms selected from oxygen and nitrogen, and where any member of the alkyl, aryl or cycloalkyl group is optionally substituted with halogen, lower alkyl or lower alkoxy, aryl or substituted aryl, andwhereR3 can be ribose, deoxyribose or phosphorylated derivatives thereof,whereinR1, R2, and R3 are not all hydrogen andwhereinwhen R3 is ribose, deoxyribose or phosphorylated derivatives thereof, one of R1 or R2 is not hydrogen.